A scientific report seeking to sub-classify HCAs showed prevalence of ~ 30% HNF-1α-inactivated cases, suggesting HNF-1α as a molecular classification maker for HCA [21]. The gene discussed is HNF1A; the disease is hepatocellular adenoma.